MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/1545-5017.70095

Медицинская библиотека · Pediatric blood & cancer · 2025

Preemptive Versus Empirical Antifungal Therapy for High-Risk, Febrile, Neutropenic Solid Tumor Patients in an LMIC Setting.

Al-Qadi Omnia, Shalaby Lobna, Anany Mervat El, Zaky Iman, Naguib Maggie, Kashef Amr, Hassanain Omneya, Zamzam Manal, Lehmann Leslie, Haddad Alaa El

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Preemptive antifungal therapy in neutropenic fever offers a rational alternative to the empiric strategy, potentially reducing drug toxicity, resistance, and treatment-related costs. However, its implementation in the Middle East and North Africa (MENA) region remains insufficiently addressed.

METHODS

We prospectively observed episodes of neutropenia in pediatric patients with solid tumors and prolonged neutropenia. This non-inferiority cohort study evaluated two primary endpoints: the cumulative incidence of invasive fungal infection (IFI), IFI-attributable mortality. Outcomes from the prospective cohort managed with a preemptive strategy were compared with retrospective data from a historical cohort treated with the previously used empiric approach.

RESULTS

A total of 422 preemptive episodes were prospectively recorded, and data from 338 historical empiric episodes were retrospectively reviewed. The incidence of IFI was comparable between the two groups (4.5% in the preemptive group vs. 5.6% in the empiric group; p = 0.5). However, antifungal use was significantly lower in the preemptive group (5.0% vs. 58.0%; p < 0.001). Overall survival was higher in the preemptive group (98.9% vs. 94.6%). No IFI-attributable mortality was recorded in either group.

INTERPRETATION: The combined EIA/HRCT-based preemptive strategy is feasible and associated with reduced antifungal use without compromising patient outcomes in pediatric patients with solid tumors and prolonged neutropenia.

Для цитирования: Al-Qadi Omnia, Shalaby Lobna, Anany Mervat El, Zaky Iman, Naguib Maggie, Kashef Amr, Hassanain Omneya, Zamzam Manal, Lehmann Leslie, Haddad Alaa El. Preemptive Versus Empirical Antifungal Therapy for High-Risk, Febrile, Neutropenic Solid Tumor Patients in an LMIC Setting.. Pediatric blood & cancer. 2025. DOI: 10.1002/1545-5017.70095.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.